EKSO
Ekso Bionics Holdings Inc.
$5.39
+$0.29(+5.69%)
60
Overall
60
Value
70
Tech
52
Quality
Market Cap
$11.54M
Volume
50.26K
52W Range
$2.73 - $14.97
Target Price
$6.75
Order:
Income Statement
| Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $8.7M | $14.2M | $7.4M | $11.3M | $13.9M | $8.9M | $11.2M | $12.9M | $18.3M | $17.9M | ||
| Total Revenue | $8.7M | $14.2M | $7.4M | $11.3M | $13.9M | $8.9M | $11.2M | $12.9M | $18.3M | $17.9M | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $7.5M | $11.3M | $-5.3M | $-7.0M | $-7.2M | $3.8M | $4.5M | $6.7M | $9.2M | $8.4M | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $1.2M | $2.9M | $2.1M | $4.3M | $6.8M | $5.1M | $6.7M | $6.2M | $9.1M | $9.5M | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $22.7M | $30.7M | $-33.7M | $-31.3M | $-23.4M | $18.4M | $20.6M | $21.8M | $24.2M | $20.0M | ||
| Research & Development | $6.5M | $8.9M | $9.5M | $5.8M | $4.6M | $2.5M | $2.5M | $3.6M | $5.0M | $3.9M | ||
| Research Expense | $6.5M | $8.9M | $9.5M | $5.8M | $4.6M | $2.5M | $2.5M | $3.6M | $5.0M | $3.9M | ||
| Selling, General & Administrative | $16.3M | $21.9M | $23.9M | $25.5M | $18.8M | $15.5M | $18.0M | $18.1M | $19.2M | $16.1M | ||
| Selling & Marketing Expenses | $9.3M | $11.0M | $13.2M | $13.8M | $11.4M | $7.8M | $7.3M | $7.2M | $8.5M | $7.3M | ||
| General & Administrative Expenses | $7.0M | $10.9M | $10.7M | $11.7M | $7.4M | $7.7M | $10.7M | $11.0M | $10.7M | $8.8M | ||
| Promotion & Advertising | $-25.0K | $-108.0K | $-160.0K | $-123.0K | $-14.0K | -- | -- | -- | -- | -- | ||
| Salaries & Wages | $-1.7M | $-3.1M | $-2.4M | $-2.9M | $-2.3M | $-50.0K | -- | -- | $1.9M | $1.4M | ||
| Depreciation & Amortization | $-933.0K | $-1.9M | $-1.2M | $-1.0M | $-690.0K | $620.0K | $561.0K | $486.0K | $726.0K | $658.0K | ||
| Depreciation & Amortization | $-933.0K | $-1.9M | $-1.2M | $-1.0M | $-690.0K | $620.0K | $561.0K | $486.0K | $726.0K | $658.0K | ||
| Amortization | $-1.4M | $-558.0K | $-535.0K | $-32.0K | $-19.0K | -- | -- | $5.2M | $4.9M | $4.6M | ||
| Other Operating Expenses | -- | $-146.0K | $-332.0K | $-35.0K | $-55.0K | $-7.0K | $-22.0K | $-48.0K | $-1.2M | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $-21.6M | $-27.8M | $-38.3M | $-38.4M | $-30.6M | $-13.3M | $-13.8M | $-15.6M | $-15.1M | $-10.5M | ||
| EBITDA | $-18.7M | $-21.6M | $-26.7M | $-25.3M | $-11.3M | $-15.1M | $-8.6M | $-14.0M | $-13.5M | $-9.5M | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $13.0K | $16.0K | $648.0K | $600.0K | $384.0K | $139.0K | $113.0K | $156.0K | $302.0K | $269.0K | ||
| Interest Income Operating | -- | -- | $3.9M | -- | -- | -- | -- | -- | -- | -- | ||
| Intinc | $11.0K | $12.0K | $2.8M | $1.1M | $5.0M | -- | -- | -- | -- | -- | ||
| Net Non-Operating Interest Income/Expense | $-2.0K | $-4.0K | $2.2M | $463.0K | $4.6M | $-139.0K | $-113.0K | $-156.0K | $-302.0K | -- | ||
| Gain on Sale of Securities | -- | $196.0K | -- | -- | -- | -- | -- | $1.3M | $-133.0K | $474.0K | ||
| Other Income/Expense | $-2.0M | $-4.3M | $-7.6M | $-10.9M | $-13.8M | $2.4M | $-5.0M | $632.0K | $196.0K | $-473.0K | ||
| Other Special Charges | $2.0M | $-166.0K | $7.6M | $10.9M | $13.8M | $-2.4M | $5.0M | $-30.0K | $-63.0K | $-1.0K | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $19.6M | -- | $659.0K | $-82.0K | $-49.0K | $244.0K | -- | -- | -- | -- | ||
| Special Income Charges | $-19.6M | -- | $-659.0K | $82.0K | $49.0K | $-433.0K | -- | -- | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $189.0K | -- | -- | -- | -- | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $-19.6M | $-23.5M | $-28.5M | $-26.8M | $-12.0M | $-15.7M | $-9.7M | $-14.9M | $-15.2M | $-11.1M | ||
| Pre-Tax Income | $-19.6M | $-23.5M | $-29.1M | $-27.0M | $-12.1M | $-15.8M | $-9.8M | $-15.1M | $-14.9M | $-11.3M | ||
| NET INCOME | ||||||||||||
| Net Income | $-19.6M | $-23.5M | $-29.1M | $-27.0M | $-12.1M | $-15.8M | $-9.8M | $-15.1M | $-15.2M | $-11.3M | ||
| Net Income (Continuing Operations) | $-19.6M | $-23.5M | $-29.1M | $-27.0M | $-12.1M | $-15.8M | $-9.8M | $-15.1M | $-15.2M | $-11.3M | ||
| Net Income (Discontinued Operations) | $-19.6M | $-23.5M | $-29.1M | $-27.0M | $-12.1M | $-15.8M | $-9.8M | $-15.1M | $-15.2M | $-11.3M | ||
| Net Income (Common Stockholders) | $-14.9M | $-13.1M | $-29.1M | $-27.0M | $-12.1M | $-15.8M | $-9.8M | $-15.1M | $-15.2M | $-11.3M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-7.7M | -- | -- | $-10.8M | ||
| TOTALS | ||||||||||||
| Total Expenses | $30.2M | $42.0M | $-39.0M | $-38.4M | $-30.6M | $22.2M | $25.1M | $28.5M | $33.4M | $28.4M | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $64.9K | $80.6K | $158.3K | $272.1K | $319.6K | $477.6K | $812.9K | $864.1K | $924.5K | $20.2M | ||
| Average Shares Outstanding (Diluted) | $64.9K | $82.8K | $158.3K | $272.1K | $319.6K | $477.6K | $817.9K | $864.1K | $924.5K | $20.2M | ||
| Shares Outstanding | $68.9K | $97.3K | $267.6K | $285.6K | $386.9K | $840.0K | $846.2K | $889.4K | $1.2M | $24.8M | ||
| Basic EPS | $-378 | $-420.75 | $-184.5 | $-99 | $-38.25 | $-33.15 | $-12 | $-17.4 | $-16.5 | $-0.56 | ||
| Basic EPS (Continuing Operations) | $-378 | $-420.75 | -- | -- | -- | $-33.15 | $-12 | $-17.4 | $-16.5 | $-0.56 | ||
| Diluted EPS | $-409.5 | $-461.25 | $-184.5 | $-99 | $-38.25 | $-33.15 | $-13.2 | $-17.4 | $-16.5 | $-0.56 | ||
| Diluted EPS (Continuing Operations) | $-409.5 | $-461.25 | -- | -- | -- | $-33.15 | $-13.2 | $-17.4 | $-16.5 | -- | ||
| OTHER METRICS | ||||||||||||
| Accrued Preferred Stock Dividends | $-4.7M | $-10.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings from equity interest | -- | -- | -- | -- | -- | $-66.0K | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | $-66.0K | -- | -- | -- | -- | ||
| Gain On Sale Of Business | -- | $4.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Interest Expense Operating | -- | -- | -- | $-441.0K | $-278.0K | -- | -- | -- | -- | -- | ||
| Other Gand A | $7.0M | $10.9M | $10.7M | $11.7M | $7.4M | $7.7M | $10.7M | $11.0M | $10.7M | $8.8M | ||
| Otherunder Preferred Stock Dividend | $-4.7M | $-10.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $-4.7M | $-10.3M | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $-342.0K | $-400.0K | $10.7M | $11.7M | $7.4M | -- | -- | -- | -- | -- | ||
| Selling Expense | -- | -- | $13.2M | $13.8M | $11.4M | -- | -- | -- | -- | -- | ||
| Restruct | $19.6M | -- | $659.0K | $-82.0K | $-49.0K | $244.0K | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EKSO | $5.39 | +5.7% | 50.26K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Ekso Bionics Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW